PDCD4

PDCD4

Target · Tumour suppressor

PDCD4 Programmed cell death protein 4 · neoplastic transformation inhibitor

PDCD4 (programmed cell death 4, also known as H731) is an RNA-binding tumour suppressor that inhibits cap-dependent translation initiation. It acts through the helicase EIF4A1 and also modulates JUN kinase signalling. Browse Assay Genie's current range of PDCD4 research reagents below, or read on for the biology behind the target.

Nucleus and cytoplasmTranslation initiation inhibitorTumour suppressor protein
469 aa
Protein length
~52 kDa
Molecular weight
10q25.2
Gene locus
PDCD4 family
Protein family
Target information

What is PDCD4 (programmed cell death 4)?

PDCD4 inhibits translation initiation and cap-dependent translation. It is thought to act by hindering the interaction between EIF4A1 and EIF4G, and it inhibits the helicase activity of EIF4A. The NCBI Gene summary describes the protein as binding to eukaryotic translation initiation factor 4A1 and blocking its function by preventing RNA binding. The protein itself also binds RNA.

Beyond translational control, PDCD4 modulates the activation of JUN kinase. It down-regulates expression of MAP4K1, which restrains MAPK85 activation and the consequent JUN-dependent transcription, events important in driving invasion. PDCD4 may also play a role in apoptosis. It is classed as a tumour suppressor and inhibits tumour promoter-induced neoplastic transformation, which is why researchers studying cancer biology and translation regulation often examine the PDCD4 protein.

The PDCD4 gene belongs to the HGNC group of microRNA protein coding host genes, and the protein belongs to the PDCD4 family. UniProt lists the protein in the nucleus and the cytoplasm. Alternative splicing of the gene produces multiple transcript variants. The previous HGNC name, programmed cell death 4 (neoplastic transformation inhibitor), reflects its role in suppressing transformation. Mouse and rat both have a Pdcd4 ortholog.

Translation initiation control

PDCD4 inhibits cap-dependent translation and the helicase activity of EIF4A, making it a useful subject for studying how initiation is regulated.

Tumour suppressor biology

PDCD4 is a tumour suppressor that inhibits tumour promoter-induced neoplastic transformation, so it is studied in transformation and cancer research.

JUN kinase and invasion signalling

PDCD4 modulates JUN kinase activation and down-regulates MAP4K1, linking it to the JUN-dependent transcription that drives invasion.

Apoptosis and RNA binding

PDCD4 may play a role in apoptosis and binds RNA, supporting work on cell death and RNA-protein interactions.

Background

PDCD4 frequently asked questions

What does PDCD4 do?

PDCD4 inhibits translation initiation and cap-dependent translation, probably by hindering the EIF4A1–EIF4G interaction and inhibiting EIF4A helicase activity. It also modulates JUN kinase activation, may play a role in apoptosis, and acts as a tumour suppressor that binds RNA.

What other names does PDCD4 have, and does it have isoforms?

PDCD4 is also known as H731. Its earlier HGNC name was programmed cell death 4 (neoplastic transformation inhibitor). UniProt names the protein programmed cell death protein 4. NCBI reports that alternative splicing of the gene gives multiple transcript variants.

Is PDCD4 conserved across species?

Yes. The data list Pdcd4 orthologs in both mouse and rat. Researchers should check the datasheet of any product for its validated reactivity before using it in a given species.

Explore

Related targets

Other programmed cell death family proteins that researchers often study alongside PDCD4.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q53EL6; product specifications from Assay Genie datasheets.

PDCD4 Product listing